...
首页> 外文期刊>The biochemical journal >Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat α1-proteinase inhibitor and α1-acid glycoprotein
【24h】

Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat α1-proteinase inhibitor and α1-acid glycoprotein

机译:葡萄糖苷酶抑制剂1-脱苏昔尼霉素,N-甲基-1-脱苏约尼霉素和氨基吡咯胺对大鼠α1蛋白酶抑制剂和α1-酸糖蛋白的糖基化的不同效果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

pThe glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine were used to inhibit oligosaccharide processing in primary cultures of rat hepatocytes. Their effect on the glycosylation of alpha 1-proteinase inhibitor (alpha 1PI) and alpha 1-acid glycoprotein (alpha 1AGP) was studied. Of the three glucosidase inhibitors examined, 1-deoxynojirimycin inhibited not only oligosaccharide trimming but also glycosylation de novo of newly synthesized proteins, resulting in the formation of alpha 1PI with two and three (normally carrying three) and alpha 1AGP with two to five (normally carrying six) oligosaccharide side chains. In the presence of the glucosidase inhibitors, glucosylated high-mannose-type oligosaccharides accumulated. Whereas most of the endoglucosaminidase-H-sensitive oligosaccharides formed in the presence of 1-deoxynojirimycin contained only one glucose residue, N-methyl-1-deoxynojirimycin and castanospermine led mainly to the formation of oligosaccharides with three glucose residues. None of the three glucosidase inhibitors completely prevented the formation of complex-type oligosaccharides. Thus, in their presence, alpha 1PI and alpha 1AGP with a mixture of both high-mannose and complex-type oligosaccharides were secreted./p
机译:>葡萄糖苷酶抑制剂1-脱苏昔尼霉素,N-甲基-1-脱氧尼霉素和氨基吡霉素用于抑制大鼠肝细胞的原发性培养物中的低聚糖加工。研究了对α1-蛋白酶抑制剂(α1PI)和α1-酸糖蛋白(α1Agp)的糖基化的影响。在检查的三种葡糖苷酶抑制剂中,1-脱氧胆嘧啶抑制不仅寡糖修剪,而且抑制了新合成的蛋白质的糖基化De Novo,导致α1Pi形成两和三(通常携带三个)和α1agp,两到五(通常)携带六个)寡糖侧链。在葡萄糖苷酶抑制剂存在下,积累的葡萄糖基化的高甘露糖型低聚糖。而在存在1-脱苏尼霉素的存在下形成的大多数内葡萄糖氨基氨基氨基氨基氨基胺 - H敏感寡糖仅含有一个葡萄糖残基,N-甲基-1-脱苏昔尼霉素和CastanoSpermine主要用于形成具有三种葡萄糖残基的寡糖。三种葡萄糖苷酶抑制剂中没有一种完全阻止形成复合型低聚糖。因此,在它们存在下,分泌α1PI和α1AGP,用高甘露糖和复合型低聚糖的混合物分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号